Fukuoka, Japan

Hiroshi Yasumatsu

This inventor holds 2 USPTO granted patents. Top assignees: Mitsubishi Pharma Corporation, Welfide Corporation. Active years: 2001-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Yasumatsu. Retrieved from https://idiyas.com/inventor/hiroshi-yasumatsu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Location History:

  • Chikujo-gun, JP (2001)
  • Fukuoka, JP (2002)

Company Filing History:


Years Active: 2001-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hiroshi Yasumatsu: Innovator in Thiophene Compounds

Introduction

Hiroshi Yasumatsu is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of chemistry, particularly in the development of thiophene compounds. With a total of 2 patents, his work has implications in the pharmaceutical industry.

Latest Patents

Yasumatsu's latest patents include "Condensed thiophene compounds and pharmaceutical use thereof" and "Fused thiophene compounds and medicinal use thereof." These innovations focus on the medicinal applications of condensed thiophene compounds, showcasing his expertise in this specialized area.

Career Highlights

Throughout his career, Yasumatsu has worked with prominent companies such as Welfide Corporation and Mitsubishi Pharma Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in medicinal chemistry.

Collaborations

Yasumatsu has collaborated with esteemed colleagues, including Koji Seio and Hiroshi Tanaka. These partnerships have fostered a creative environment that has led to innovative solutions in their field.

Conclusion

Hiroshi Yasumatsu's contributions to the development of thiophene compounds highlight his role as a significant inventor in the pharmaceutical industry. His work continues to influence advancements in medicinal chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…